Potential Biomarkers for the Efficacy of PD-1-PD-L Blockade in Cancer

A decade ago, immune checkpoint blockade emerged as a major breakthrough in oncology, proposing a novel approach by which immune brakes could be released to enhance antitumor responses. Despite apparently modest improvement of the median duration of response, a spectacular doubling of long-term resp...

Descripción completa

Detalles Bibliográficos
Autores principales: Grecea, Miruna, Soritau, Olga, Dulf, Daniel, Ciuleanu, Tudor Eliade, Zdrenghea, Mihnea
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627113/
https://www.ncbi.nlm.nih.gov/pubmed/34848970
http://dx.doi.org/10.2147/OTT.S283892

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627113/
https://www.ncbi.nlm.nih.gov/pubmed/34848970
http://dx.doi.org/10.2147/OTT.S283892

Ejemplares similares